Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK44459 Tablets in Moderate-to-Severe Plaque Psoriasis (Phase II)
CTR20253507Phase 2Active
- Sponsor
- Haisco-Sirnaomics
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HSK44459 in plaque psoriasis, sponsored by Haisco-Sirnaomics. Started Sep 2025; status: active.
02
Drugs
HSK44459
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20253507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253507.